N.Y. Public Health Law § 277: Review and reports

§ 277. Review and reports. 1. The commissioner, in consultation with

the drug utilization review board, shall undertake periodic reviews, at

least annually, of the preferred drug program which shall include

consideration of:

(a) the volume of prior authorizations being handled, including data

on the number and characteristics of prior authorization requests for

particular prescription drugs;

(b) the quality of the program's responsiveness, including the quality

of the administrator's responsiveness;

(c) complaints received from patients and providers;

(d) the savings attributable to the state, and to each county and the

city of New York, due to the provisions of this article;

(e) the aggregate amount of supplemental rebates received in the

previous fiscal year and in the current fiscal year, to date; and such

amounts are to be broken out by fiscal year and by month;

(f) the education and outreach program established by section two

hundred seventy-six of this article.

2. The commissioner and the board shall, beginning March thirty-first,

two thousand six and annually thereafter, submit a report to the

governor and the legislature concerning each of the items subject to

periodic review under subdivision one of this section.

3. The commissioner and the board shall, beginning with the

commencement of the preferred drug program and monthly thereafter,

submit a report to the governor and the legislature concerning the

amount of supplemental rebates received.